Magnesium and Minitran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Magnesium (magnesium) and Minitran (nitroglycerin). Common drug interactions include blood potassium increased among females and hypertension among males.

The phase IV clinical study analyzes what interactions people have when they take Magnesium and Minitran. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Magnesium?

Magnesium has active ingredients of magnesium. It is often used in constipation. eHealthMe is studying from 121,147 Magnesium users. Check the latest studies of Magnesium.

What is Minitran?

Minitran has active ingredients of nitroglycerin. eHealthMe is studying from 950 Minitran users. Check the latest studies of Minitran.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

21 people who take Magnesium and Minitran together, and have interactions are studied.

Magnesium and Minitran drug interactions.

What are the common drug interactions of Magnesium and Minitran, by gender? *:

female:

Blood potassium increased
Blood pressure increased
Bradycardia (abnormally slow heart action)
Cardioactive drug level decreased
Carotid artery stenosis (narrowing of carotid artery)
Chronic kidney disease
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Dementia (madness)
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Dyspepsia (indigestion)

male:

Hypertension (high blood pressure)
Asthenia (weakness)
Cardiac failure congestive
Cardiomegaly (increased size of heart than normal)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Dizziness
Dyspnoea (difficult or laboured respiration)
Hypotension (abnormally low blood pressure)
Injury
Low density lipoprotein increased (cholesterol increased in blood)

What are the common drug interactions of Magnesium and Minitran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Coagulopathy (blood's ability to clot is impaired)
Congestive cardiomyopathy (weakening of heart muscle)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Dizziness
Dyspnoea (difficult or laboured respiration)
Fall
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Humerus fracture (injury to the upper arm bone)
Hypotension (abnormally low blood pressure)

60+:

Pneumonia
Gastric ulcer (stomach ulcer)
Renal failure (kidney dysfunction)
Renal failure acute (rapid kidney dysfunction)
Abdominal distension
Abdominal pain
Agitation (state of anxiety or nervous excitement)
Anxiety
Arthralgia (joint pain)
Arthropathy

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 6 people, 28.57%
High Blood Cholesterol: 3 people, 14.29%
Gastric Ulcer (stomach ulcer): 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium and Minitran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously